122 related articles for article (PubMed ID: 38801793)
1. A blood-based 3-gene signature score for therapeutic monitoring in patients with pulmonary tuberculosis.
Zhang P; Zheng J; Han T; Ma J; Gnanashanmugam D; Li M; Tang YW; Deng G
Tuberculosis (Edinb); 2024 Jul; 147():102521. PubMed ID: 38801793
[TBL] [Abstract][Full Text] [Related]
2. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
[TBL] [Abstract][Full Text] [Related]
3. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
Magee MJ; Kempker RR; Kipiani M; Gandhi NR; Darchia L; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
Int J Tuberc Lung Dis; 2015 Jun; 19(6):685-92. PubMed ID: 25946360
[TBL] [Abstract][Full Text] [Related]
5. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL
Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793
[TBL] [Abstract][Full Text] [Related]
6. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
[TBL] [Abstract][Full Text] [Related]
7. Survey of tuberculosis drug resistance among Tibetan refugees in India.
Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM
Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934
[TBL] [Abstract][Full Text] [Related]
8. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis.
Dharmadhikari AS; Mphahlele M; Venter K; Stoltz A; Mathebula R; Masotla T; van der Walt M; Pagano M; Jensen P; Nardell E
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1019-25. PubMed ID: 25189547
[TBL] [Abstract][Full Text] [Related]
9. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection in the treatment of 43 patients with well-localized, cavitary pulmonary multidrug-resistant tuberculosis in Shanghai.
Xie B; Yang Y; He W; Xie D; Jiang G
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):455-9. PubMed ID: 23748869
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
Magee MJ; Kempker RR; Kipiani M; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
PLoS One; 2014; 9(4):e94890. PubMed ID: 24736471
[TBL] [Abstract][Full Text] [Related]
12. Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.
Menzies HJ; Moalosi G; Anisimova V; Gammino V; Sentle C; Bachhuber MA; Bile E; Radisowa K; Kachuwaire O; Basotli J; Maribe T; Makombe R; Shepherd J; Kim B; Samandari T; El-Halabi S; Chirenda J; Cain KP
Int J Tuberc Lung Dis; 2014 Sep; 18(9):1026-33. PubMed ID: 25189548
[TBL] [Abstract][Full Text] [Related]
13. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
[TBL] [Abstract][Full Text] [Related]
14. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
[TBL] [Abstract][Full Text] [Related]
15. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
Shibabaw A; Gelaw B; Wang SH; Tessema B
PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients.
Hong MS; Kim Y; Cho EJ; Lee JS; Kwak HK; Kim JH; Kim CT; Cho JS; Park SK; Jeon D; Choi YI; Lee H; Eum SY
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2063-2072. PubMed ID: 28620844
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
[TBL] [Abstract][Full Text] [Related]
18. Pyrazinamide may improve fluoroquinolone-based treatment of multidrug-resistant tuberculosis.
Chang KC; Leung CC; Yew WW; Leung EC; Leung WM; Tam CM; Zhang Y
Antimicrob Agents Chemother; 2012 Nov; 56(11):5465-75. PubMed ID: 22869570
[TBL] [Abstract][Full Text] [Related]
19. Performance of the MTBDRsl assay in Georgia.
Tukvadze N; Bablishvili N; Apsindzelashvili R; Blumberg HM; Kempker RR
Int J Tuberc Lung Dis; 2014 Feb; 18(2):233-9. PubMed ID: 24429319
[TBL] [Abstract][Full Text] [Related]
20. Improvement in plasma drug activity during the early treatment interval among Tanzanian patients with multidrug-resistant tuberculosis.
Ndusilo ND; Heysell SK; Mpagama SG; Gratz J; Segesela FH; Pazia SJ; Wang XQ; Houpt ER; Kibiki GS
PLoS One; 2015; 10(3):e0122769. PubMed ID: 25816161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
